Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Genmab
Memorial Sloan Kettering Cancer Center
New York Medical College
St. Jude Children's Research Hospital
Instil Bio
Aura Biosciences
Genentech, Inc.
City of Hope Medical Center
C Ray Therapeutics
Shanghai Henlius Biotech
National Institutes of Health Clinical Center (CC)
Kura Oncology, Inc.
University of Texas Southwestern Medical Center
Incyte Corporation
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Aragon Pharmaceuticals, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Aragon Pharmaceuticals, Inc.
Janssen Research & Development, LLC
National Cancer Institute (NCI)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Janssen Research & Development, LLC
National Cancer Institute (NCI)
Janssen Pharmaceutical K.K.
Janssen Research & Development, LLC
Eli Lilly and Company
National Cancer Institute (NCI)
Context Therapeutics Inc.
Nammi Therapeutics Inc
Janssen Research & Development, LLC
National Cancer Institute (NCI)
Janssen Research & Development, LLC
EMD Serono
EvolveImmune United, Inc
Canadian Cancer Trials Group
Janssen Research & Development, LLC
IDEAYA Biosciences
OncoC4, Inc.
Acerand Therapeutics Limited
Compass Therapeutics
Dana-Farber Cancer Institute
AbbVie
Exscientia AI Limited